Workout
Healthy Eating Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process Contact Us
Health Tracker
AI Tools
✔Fact Checked

Atlético de Madrid prepares offer for the Barcelona defender

Article Updated On:
Photo of author
FitToFar
Published On:

Atlético de Madrid and Barcelona have been common partners in the transfer market in recent years, and it seems that they will do business next summer. The two parties are already in talks to make Clement Lenglet’s loan permanent.

The French centre-back has been on the exit ramp for some time, but Atlético could finally be his permanent destination after two loan spells at Tottenham Hotspur and Aston Villa. Los Colchoneros have him on loan for this season, and he has earned the trust of Diego Simeone, becoming a starter in recent months.

Rubén Uría has reported that Atlético and Barcelona are already in talks to reach an agreement and are willing to offer between 8 and 10 million euros for his services. The Blaugrana recently extended his contract until 2028, but both parties are interested in reaching an agreement.

The Frenchman’s high wages have often been an obstacle in negotiations for both Barcelona and his potential suitors, but at 29, Lenglet appears happy to have found a home in the Spanish capital. Overall, he has been a consistent option in La Liga, but now looks comfortable again with Simeone, in La Liga’s best defense.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

Read This Next


dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.

 

SHARE YOUR FEEDBACK

SHARE YOUR FEEDBACK